A Higher Dose of Popular GLP-1 Drug Available
- The U.S. Foods and Drug Administration has approved a new 7.2 mg dose of the popular weight loss drug semaglutide, better known as Wegovy, expanding beyond the previous 2.4 mg maximum and reinforcing the drug’s role in weight loss, blood sugar control, and reduced risk of diabetes and several cancers through its GLP‑1 hormone effects.
- Experts say GLP‑1 agonists offer broad health benefits—including improved metabolic control and lower risk of weight‑related conditions—while the higher‑dose approval follows the recent launch of the oral version, which tens of thousands have already begun using.
- “Some of the benefits for using GLP-1 agonists can be weight loss, improvement in glycemic control or blood glucose, decreased risk of weight-related conditions such as various cancers, like breast cancer, endometrial cancer, colon cancer, liver disease,” Dr. Holly Lofton, director of the Medical Weight Management Program at NYU Langone, says.
- Weight loss of more than 10%—whether through bariatric surgery (procedures that reduce stomach size) or GLP‑1 medications like Wegovy or Ozempic—has been linked to modest reductions in obesity‑related cancer risk, according to a new study released in JAMA. However, researchers say more randomized clinical trials are still needed to confirm the effect.
The widely used weight‑loss medication semaglutide, best known by its brand name Wegovy, is now available in a higher dose following new authorization from the U.S. Food and Drug Administration.
The newly approved 7.2 mg dose is significantly higher than the previous maximum of 2.4 mg. Read MoreWATCH: GLP-1 Weight Loss Drugs and Cancer
“GLP‑1s are amazing medications. They change people’s lives in terms of cardiac risk and diabetes. They have widespread benefits,” says Dr. Samantha Newman of Memorial Sloan Kettering Cancer Center, speaking with SurvivorNet.
Integral to blood sugar control, GLP-1 is a hormone released by the gut in response to food. It causes the pancreas to release insulin. A rising blood insulin level causes all body tissues to absorb glucose (blood sugar) from the bloodstream, lowering blood glucose levels.
GLP-1 also prevents the release of glucagon, a hormone that raises blood sugar levels by stimulating liver cells to release glucose, and helps people feel full for longer. These effects can also cause people to lose weight.
The higher-dose semaglutide comes just a couple of months after the FDA approved the oral version of the weight-loss drug, which was previously available only as an injectable.
SurvivorNet previously reported that tens of thousands have already started the medication, which not only supports weight loss but also reduces the risk of diabetes and several cancers.
“Some of the benefits for using GLP-1 agonists can be weight loss, improvement in glycemic control or blood glucose, decreased risk of weight-related conditions such as various cancers, like breast cancer, endometrial cancer, colon cancer, liver disease,” Dr. Holly Lofton, director of the Medical Weight Management Program at NYU Langone in Manhattan, tells SurvivorNet.
Cancer Risk and Obesity
A study published in JAMA adds fresh evidence to a long‑standing concern: obesity can be linked to roughly 10% of all new cancer diagnoses in the United States each year, and for certain cancers, it may account for up to half of all cases.
“One of the biggest takeaways from this paper is that people with classical obesity often need to lose more than 10% of their body weight to meaningfully reduce cancer risk,” said Dr. Neil Iyengar, Associate Professor, and Co-director of Breast Medical Oncology, and Director of Cancer Survivorship at Emory Winship Cancer Institute.
“Diet, exercise, and lifestyle changes are essential for maintaining a healthy weight, but reaching that level of weight loss can be incredibly difficult for many. That’s why the discussion also includes tools like GLP‑1 receptor agonists and bariatric surgery, which can help support the kind of significant weight loss associated with lowering cancer risk,” Dr. Iyengar told SurvivorNet.
For years, scientists have warned that carrying excess body weight creates a biological environment where cancer can thrive. According to the study’s authors, obesity is associated with a higher incidence of cancers, including:
- Endometrial
- Esophageal
- Gastric
- Renal
- Colorectal
- Liver, gallbladder, and bile duct (hepatobiliary cancers)
- Pancreatic
- Prostate
- Postmenopausal breast
- Ovarian
- Thyroid
- Multiple myeloma
The researchers estimate that overweight and obesity contribute to 10% of new cancer diagnoses annually, and up to 50% of endometrial and hepatobiliary cancers, such as liver, gallbladder, and bile ducts.
Research published in the journal “Cancers” says that “Obesity also increases the risk of dying from cancer and may influence the treatment choices. About 4–8% of all cancers are attributed to obesity.”
WATCH: Obesity and Cancer Risk
To learn more about your ideal healthy weight, determine your body mass index (BMI).
Body weight that exceeds what the body mass index deems appropriate for your weight and height can help determine body fat content. Although your BMI can help you learn if you are at a healthy weight, underweight, overweight, or obese, other factors may contribute to your overall health.
The National Cancer Institute analyzed several studies to observe the impact of physical activity on overall cancer risk. The NCI says that “higher levels of physical activity are linked to lower risk of several types of cancer.”
Regular exercise, a balanced diet, and managing stress are some ways people can practice leading a healthy life. For cancer survivors, a healthier lifestyle alongside getting regular checks for recurrence may improve their quality of life.
“Excess weight is one of the most important causes of cancer, second only to smoking, which it may even overtake in the coming years,” Dr. Graham Colditz, Director, Division of Public Health Sciences at WashU Medicine and Siteman Cancer Center.
“As rates of overweight and obesity continue to rise, we need to invest in effective systemic changes to help prevent weight gain and to help with weight loss. This can include better infrastructure that promotes activity, better access to affordable, healthy foods, and insurance that covers weight and diet counseling,” Dr. Colditz adds.
How Excess Weight Fuels Tumor Growth
The study outlines several interconnected biological pathways that help explain why obesity increases cancer risk. They involve inflammation, hormone changes, immune suppression, and shifts in the gut microbiome.
The study outlines several interconnected biological pathways that help explain why obesity increases cancer risk, including inflammation, hormone changes, immune suppression, and shifts in the gut microbiome. Dr. Iyengar says these processes begin with the way excess fat tissue disrupts the body’s normal balance.
“In the setting of obesity, the environment in a person’s body is just ripe for the growth of tumors and cancer. When you have excess adipose (fat) tissue, the normal function of fat tissue is to store energy and maintain energy homeostasis… When we have too much fat tissue, the fat tissue can no longer function properly.”
- Inflammation and Hormone Disruption
- Excess adipose (fat) tissue becomes biologically active, producing inflammatory molecules and altering hormone levels. This includes:
– Increased estrogen and leptin
– Decreased adiponectin
– Elevated inflammatory mediators such as prostaglandin E2, IL‑1β, IL‑6, and TNF‑α - These changes can directly stimulate tumor growth or indirectly promote cancers that are sensitive to hormones, such as breast, ovarian, and endometrial cancers.
- Excess adipose (fat) tissue becomes biologically active, producing inflammatory molecules and altering hormone levels. This includes:
- Immune System Suppression
- Obesity is linked to the accumulation of myeloid-derived suppressor cells, which weaken the body’s ability to detect and destroy emerging cancer cells. At the same time, the function of cytotoxic T cells and natural killer cells — the immune system’s frontline defenders — is reduced.
- Genomic Instability and Oxidative Stress
- Chronic inflammation and excess free fatty acids create oxidative stress, which can damage DNA and impair the body’s ability to repair it. This increases the likelihood of gene mutations that can lead to cancer development.
“Dysfunctional fat tissue can cause inflammation,” Dr. Iyengar explains.
As that tissue becomes dysfunctional, he explains, it releases energy in the form of free fatty acids into the bloodstream—fuel that cancer cells can readily use. Those circulating fatty acids also trigger insulin resistance, creating even more metabolic stress.
“Extra energy causes stress in our body known as oxidative stress, and that’s what causes DNA damage… if there’s enough DNA damage, that can lead to just the right type of mutation in a cell that is a cancer mutation,” Dr. Iyengar explained.
- Gut Microbiome Disruption
- Obesity is associated with a loss of beneficial gut bacteria (such as Akkermansia muciniphila) and an overgrowth of species linked to inflammation and cancer development (such as Bilophila). These shifts further heighten inflammation and oxidative stress.
“We know that obesity changes the types of bacteria that live in our gut… what you see in the gut bacteria of people with obesity is that it’s bacteria that create more inflammation,” Dr. Iyengar said.
WATCH: The Link Between Obesity and Prostate Cancer
Can Weight Loss Reduce Cancer Risk?
The study suggests that meaningful weight loss — more than 10% of body weight — may help lower cancer risk, but the effect varies by cancer type.
Evidence comes from large observational groups:
Bariatric surgery patients (n = 30,318). These patients underwent some form of minimally invasive (laparoscopic/robotic) weight-loss surgery that reduced their stomach size.
People using GLP‑1 receptor agonists such as semaglutide or tirzepatide (n = 1,651,452)
Across these groups, cancer incidence dropped by 0.02% to 0.5%, respectively, indicating a measurable but not dramatic reduction.
Researchers emphasize that randomized clinical trials are still needed to confirm whether weight loss directly reduces cancer risk or whether other factors contribute.
“There is no one single mechanism, but likely many mechanisms that can explain these links between cancer and obesity,” said Dr. Stephen Freedland, Director of the Center for Integrated Research in Cancer and Lifestyle, Co-Director of the Cancer Genetics and Prevention Program, and Associate Director for Faculty Development at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai.
“Preliminary data suggest significant weight loss, perhaps with the help of GLP1 receptor agonists, may help reduce these risks. In terms of prostate cancer, we see clear links between obesity and aggressive prostate cancer, progression after treatment, and death from prostate cancer. The impact of lifestyle interventions and ultimately weight loss to reduce these risks is ongoing,” Dr. Freedland continued.
WATCH: Exercise Can Lower Your Breast Cancer Risk
Tips to Live a Healthier Life
Dr. Ken Miller, the director of outpatient oncology at the University of Maryland Greenebaum Cancer Center, recommends these four things for cancer survivors to do to try to avoid another cancer diagnosis:
- Exercise at least two hours a week; walking counts
- Eat a low-fat diet
- Eat a colorful diet with lots of fruits and vegetables; doctors recommend two to three cups a day
- Maintain a healthy weight
Learn more about SurvivorNet's rigorous medical review process.
